The function of necroptosis in liver cancer

Biochim Biophys Acta Mol Basis Dis. 2025 Aug;1871(6):167828. doi: 10.1016/j.bbadis.2025.167828. Epub 2025 Apr 10.

Abstract

Liver cancer is one of the most lethal cancers, and apoptosis resistance is a major obstacle contributing to chemotherapy failure in liver cancer treatment. Inducing cancer cell death by bypassing the apoptotic pathway is considered a promising approach to overcome this problem. Necroptosis is a non-caspase-dependent regulated mode of cell death mainly mediated by receptor-interacting protein kinase 1 (RIPK1), RIPK3, and mixed lineage kinase domain-like (MLKL) protein, and the utilization of necroptosis for treating hepatocellular carcinoma (HCC) also offers a new hope for addressing liver cancer in the clinic. In this paper, the role of necroptosis in HCC as well as the effect on differentiation of liver cancer are reviewed. We also comparatively analyze the relationship among necroptosis, apoptosis, and necrosis, as well as summarize the characteristics and functions of key proteins involved in this pathway. The bidirectional regulation of necroptosis and the mitochondrial machinery within this pathway deserve attention.

Keywords: Cancer cell differentiation; Liver cancer; Liver fibrosis; Multichannel regulation; Necroptosis.

Publication types

  • Review

MeSH terms

  • Animals
  • Apoptosis
  • Carcinoma, Hepatocellular* / genetics
  • Carcinoma, Hepatocellular* / metabolism
  • Carcinoma, Hepatocellular* / pathology
  • Humans
  • Liver Neoplasms* / genetics
  • Liver Neoplasms* / metabolism
  • Liver Neoplasms* / pathology
  • Necroptosis*
  • Necrosis
  • Protein Kinases / genetics
  • Protein Kinases / metabolism
  • Receptor-Interacting Protein Serine-Threonine Kinases / genetics
  • Receptor-Interacting Protein Serine-Threonine Kinases / metabolism
  • Signal Transduction

Substances

  • Receptor-Interacting Protein Serine-Threonine Kinases
  • RIPK1 protein, human
  • Protein Kinases
  • RIPK3 protein, human
  • MLKL protein, human